drugset / Trial / NCT03979898

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP

NCT03979898 ↗

NaSingle-groupOpen-labelTreatment

Summary

Safety and Effectiveness of Autologous Adipose Tissue Derived mesenchymal Stem Cell Implantation in Patients with CP

Timeline

Start
2017-06-15
Primary completion
2019-04-23
Completion
2019-05-13

Drugs

EvaluationDrugModalityDoseRoute
Subject AstroStem Cell therapy 5e+06 cells Intravenous
Subject AstroStem Cell therapy 1e+08 cells Intravenous
Subject AstroStem Cell therapy 1.5e+08 cells Intravenous

Indications